Publications | Lund University Publications

261 – 270 of 335

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22medf-ebe%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
26
27
28
29
…
34
next »

2003
Mark Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Björkman, S ; Blanchette, V. S. ; Fischer, K. ; Giangrande, P. L. F. ; Gringeri, A. ; Ljung, Rolf ^LU ; Manco-Johnson, M. J. and Morfini, M. , et al. (2003) In Haemophilia 9(Suppl 1). p.41278-41278
- Contribution to journal › Letter
Mark Limited protective effect of the CCR5 Delta 32/CCR5 Delta 32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus
Iversen, AKN ; Christiansen, CB ; Attermann, J ; Eugen-Olsen, J ; Schulman, S ; Berntorp, Erik ^LU ; Ingerslev, J ; Fugger, L ; Scheibel, E and Tengborn, Lilian ^LU , et al. (2003) In Journal of Infectious Diseases 187(2). p.215-225
- Contribution to journal › Article
Mark Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population
Sjalander, A ; Engstrom, G ; Berntorp, Erik ^LU and Svensson, Peter ^LU (2003) In Journal of Internal Medicine 254(5). p.434-438
- Contribution to journal › Article
Mark Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
Berntorp, Erik ^LU (2003) In Haematologica 88(6). p.3-3
- Contribution to journal › Article
Mark A Healthy Hemophilic Patient without Arthropathy: From Concept to Clinical Reality.
Berntorp, Erik ^LU and Michiels, Jan J (2003) In Seminars in Thrombosis and Hemostasis 29(1). p.5-10
- Contribution to journal › Article
Mark Elective orthopaedic surgery for inhibitor patients.
Rodriguez-Merchan, E. C. ; Wiedel, J. D. ; Wallny, T. ; Hvid, I. ; Berntorp, Erik ^LU ; Rivard, G-E ; Goddard, N. J. ; Querol, F. and Caviglia, H. (2003) In Haemophilia 9(5). p.625-631
- Contribution to journal › Article
Mark Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
Berntorp, Erik ^LU ; Piitulainen, Eeva ^LU ; Lethagen, Stefan ^LU ; Mattson, E ; Tengborn, Lilian ^LU and Mätzsch, Thomas ^LU (2003) In Haemophilia 9(2). p.173-178
- Contribution to journal › Article
Mark On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson, Katarina ^LU ; Höjgård, Sören ^LU ; Glomstein, A. ; Lethagen, Stefan ^LU ; Schulman, S. ; Tengborn, Lilian ^LU ; Lindgren, Anna ^LU ; Berntorp, Erik ^LU and Lindgren, Björn ^LU (2003) In Haemophilia 9(5). p.555-566
- Contribution to journal › Article
Mark Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
Piitulainen, Eeva ^LU ; Bernspång, Elisabeth ^LU ; Björkman, Sven and Berntorp, Erik ^LU (2003) In European Journal of Clinical Pharmacology 59(2). p.151-156
- Contribution to journal › Article
2002
Mark Progress in haemophilic care: ethical issues.
Berntorp, Erik ^LU (2002) In Haemophilia 8(3). p.435-438
- Contribution to journal › Article

« previous
1
…
26
27
28
29
…
34
next »

your query:: Remove author: Berntorp, Erik (LU)